Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS | NYSE
Chart Builder DCF Calculator
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours: Sep 21, 2026, 4:18 PM ET

Market Data

Market Cap
$350.85M
Enterprise Value
$780.06M
Beta
2.34
Average Volume
1M
Shares Outstanding (Diluted)
51.6M
Shares Change YoY
-4.8%
Institutional Ownership
83.69%
Exchange
NYSE
ISIN
US29089Q1058

Price Performance

Price Change 1M
30.7%
Price Change 3M
-18.2%
Price Change 6M
-20.2%
Price Change YTD
-47.6%
Price Change 1Y
-19.9%
Price Change 3Y
100.9%
Price Change 5Y
-87.5%
1M CAGR (ann.)
28.1%
1Y CAGR (ann.)
-12.7%
5Y CAGR (ann.)
-34.7%
All-Time CAGR
-2.7%

Valuation

PE Ratio
-1.85
Forward PE
6.54
PEG Ratio
-0.10
Forward PEG
-0.01
PS Ratio
0.44
Forward PS
0.50
PB Ratio
0.99
P/FCF Ratio
24.85
P/Adj. FCF Ratio
-63.77
P/OCF Ratio
3.47
EV/Sales
1.01
EV/EBIT
-8.20
EV/EBITDA
-32.91
EV/FCF
57.36
Earnings Yield
-54.2%
FCF Yield
4.0%
Adj. FCF Yield
-1.6%

Financial Health

Net Debt
$442.1M
Total Debt
$581.8M
Cash & Short-Term Investments
$139.7M
Total Assets
$1.12B
Current Ratio
5.42
Quick Ratio
2.95
Debt / Equity Ratio
1.70
Debt / EBITDA
-24.55
Debt / FCF
42.78
OCF / Debt
0.04
Interest Coverage
-1.07
Altman Z-Score
0.85
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
49.4%
Operating Profit Margin
-7.1%
EBITDA Margin
-3.1%
Net Profit Margin
-23.0%
FCF Margin
1.8%
Adj. FCF Margin
-0.7%
SBC / Revenue
2.5%
SBC Impact (per share)
-139.0%

Returns

Return on Assets
-15.8%
Return on Equity
-35.9%
Return on Invested Capital
-5.5%
Return on Capital Employed
-5.5%
Return on Tangible Assets
-20.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-10.4%
Revenue CAGR 5Y
-14.7%
Revenue CAGR 10Y
4.2%
EPS CAGR 3Y
93.6%
EPS CAGR 5Y
8.9%
EPS CAGR 10Y
-83.8%
FCF CAGR 3Y
-17.5%
FCF CAGR 5Y
-35.4%
FCF CAGR 10Y
-16.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
15
EPS Growth Next 3Y
42.0%
Revenue Growth Next 3Y
7.7%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.37
EPS Growth Est (next Q)
-134.9%
Revenue Est (next Q)
$123.22M
Revenue Growth Est (next Q)
-46.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$10
Price Target Upside
52.7%

Cash Flow

Operating Cash Flow
$25.4M
Free Cash Flow
$13.6M
Adj. Free Cash Flow
$-5.3M
FCF Per Share
$1.66
OCF Per Share
$1.89
OCF/S Ratio
12.7%

Income Statement

Revenue
$770.2M
Gross Profit
$380.5M
Operating Income
$-54.4M
EBITDA
$-23.7M
Net Income
$-176.8M
EPS (Diluted)
-$3.55
Revenue / Employee
$855.78K
Profit / Employee
$-196.44K
Employees
900

© 2026 bestshares.com. All rights reserved.